Publikation

Long-Term Hemorrhage and Reperfusion Rates of Coiled Aneurysms: A Single-Center Experience.

Wissenschaftlicher Artikel/Review - 03.09.2024

Bereiche
PubMed
DOI
Kontakt

Zitation
Andereggen L, Bosshart S, Marbacher S, Grüter B, Berberat J, Schubert G, Añon J, Diepers M, Steiger H, Remonda L, Philipp G. Long-Term Hemorrhage and Reperfusion Rates of Coiled Aneurysms: A Single-Center Experience. J Clin Med 2024; 13
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
J Clin Med 2024; 13
Veröffentlichungsdatum
03.09.2024
ISSN (Druck)
2077-0383
Kurzbeschreibung/Zielsetzung

The endovascular approach has emerged as standard therapy for many intracranial aneurysms (IAs) to prevent hemorrhage, yet its long-term durability varies considerably. The aim of this study was to evaluate the safety and effectiveness of an initially deliberate endovascular approach regarding IA hemorrhage rates over a long-term follow-up period. This retrospective single-center study included all consecutive patients with endovascularly treated IAs who presented between January 2008 and December 2020 with a follow-up of at least 12 months. The primary endpoint was the proportion of patients with long-term IA hemorrhage rates and reperfusion. The secondary endpoint was treatment-related morbidity and mortality. Independent risk factors for IA reperfusion over the long term were analyzed using multivariate logistic regression. Endovascular treatment was the therapy of choice for 333 patients with IAs, among whom 188 (57%) experienced rupture upon presentation. Complete coiling (Raymond I) was noted in 162 (49%) of the patients, with primary supportive devices being used in 51 (15%) patients. After a median (±SD) follow-up time of 34 ± 41 months (range 12-265 months), IA reperfusion was noted in 158 (47%), necessitating retreatment in 105 (32%) of the patients. Over the long term, hemorrhage was noted in four (1%) patients. Multivariate analysis revealed aneurysmal multilobarity (HR 1.8, 95%CI 1.2-2.7; = 0.004) and a patient age of ≥50 years (HR 1.7, 95% CI 1.1-2.5, = 0.01) as independent predictors of reperfusion over time. Intervention-related morbidity was noted in 16 (4.8%) patients, namely, thrombosis formation and contrast extravasation in 8 (2.4%) patients each, while no intervention-induced mortality was observed. In the long term, the hemorrhage rate in patients with IA with an initially more conservative endovascular approach is low. Therefore, a deliberate endovascular treatment approach might be justified.